1 Min Read
Jan 22 (Reuters) - Johnson & Johnson : * J&J says expects generic competition in early 2013 for Concerta
attention defict disorder drug * J&J says expects 2013 tax rate of 20 percent, below 2012 rate
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.